Rapport Therapeutics, Inc.
Statements
Cash Flow
All figures per share in USD.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -0.28 | -0.57 | -0.91 | -0.81 | -0.86 | -0.75 | -1.05 | -0.71 | -0.46 | -0.53 | -0.28 | -0.87 | -2.04 | |
| 0.00 | 0.00 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.01 | 0.00 | 0.00 | 0.02 | |
| 0.04 | 0.06 | 0.08 | 0.12 | 0.17 | 0.17 | 0.21 | 0.12 | 0.12 | 0.12 | 0.15 | 0.15 | 0.52 | |
| 0.12 | 0.11 | -0.16 | -0.01 | 0.17 | 0.07 | -0.02 | -0.10 | 0.10 | 0.08 | -0.02 | 0.18 | 0.32 | |
| 0.00 | 0.08 | 0.06 | 0.05 | 0.01 | 0.01 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | |
| 0.00 | -4.35 | -2.15 | -5.32 | -2.77 | 1.66 | 1.09 | 0.64 | -1.50 | -3.71 | 0.80 | 0.54 | -3.53 | |
| 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
| 4.47 | -0.01 | 3.27 | 7.92 | -0.07 | 0.00 | 0.00 | 0.00 | 7.13 | 0.01 | 0.01 | 0.03 | 5.75 | |
| 4.18 | -4.93 | 0.21 | 1.78 | -3.70 | 0.91 | 0.04 | -0.07 | 5.17 | -4.23 | 0.54 | -0.30 | 0.18 | |
| -0.29 | -0.65 | -0.96 | -0.86 | -0.86 | -0.76 | -1.06 | -0.71 | -0.46 | -0.53 | -0.28 | -0.87 | -2.05 |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.